Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
Micheal Trzoss(Arcturus Therapeutics (United States)), Leslie W. Tari(Arcturus Therapeutics (United States)), Junhu Zhang(Jilin University), Vickie Brown‐Driver(Arcturus Therapeutics (United States)), Mark A. Stidham(Arcturus Therapeutics (United States)), Thanh Lam(Arcturus Therapeutics (United States)), Bryan P. Kwan(Arcturus Therapeutics (United States)), Christopher J. Creighton(Arcturus Therapeutics (United States)), Amanda Castellano(Arcturus Therapeutics (United States)), Daniel C. Bensen(State Street (United States)), Karen Joy Shaw(Arcturus Therapeutics (United States)), Zhiyong Chen(China Guangzhou Analysis and Testing Center), Xiaoming Li(Qiqihar Medical University), John Finn(Arcturus Therapeutics (United States)), Toan B. Nguyen(Lawrence Livermore National Laboratory), Mark L. Cunningham(Arcturus Therapeutics (United States)), Felice C. Lightstone, Sergio Wong(Lawrence Livermore National Laboratory), Kirk Nelson(Arcturus Therapeutics (United States))
Cited by 81
Related Papers
The photoluminescence mechanism in carbon dots (graphene quantum dots, carbon nanodots, and polymer dots): current state and future perspective
|Nano Research|2015|2.7k
Surface Chemistry Routes to Modulate the Photoluminescence of Graphene Quantum Dots: From Fluorescence Mechanism to Up‐Conversion Bioimaging Applications
|Advanced Functional Materials|2012|1.1k
Investigation into the fluorescence quenching behaviors and applications of carbon dots
|Nanoscale|2014|455
Computational Lipidomics of the Neuronal Plasma Membrane
|Biophysical Journal|2017|310